ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,234, issued on Oct. 6, was assigned to Purdue Research Foundation (West Lafayette, Ind.).
"Canine PD-L1 antibody, antigen binding fragments thereof, and methods of use thereof" was invented by Deborah Knapp (West Lafayette, Ind.), Deepika Dhawan (West Lafayette, Ind.), Seung-Oe Lim (West Lafayette, Ind.) and Perry Kirkham (Lafayette, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Caninized antibodies and antigen binding fragments thereof are provided that bind programmed death ligand 1 in a canine subject. Methods of treating cancer in a canine subject using the caninized antibodies and/or antigen binding fragments are also provided, as are meth...